Michael Avruch - 18 Mar 2026 Form 3 Insider Report for Alpha Tau Medical Ltd. (DRTS)

Role: Director
Signature: /s/ Michael Avruch
Issuer symbol: DRTS
Transactions as of: 18 Mar 2026
Net transactions value: $0
Form type: 3
Filing time: 18 Mar 2026, 19:04:47 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Avruch Michael	Director	DAM HAMACABIM ST. 36, MODIIN, ISRAEL	/s/ Michael Avruch	18 Mar 2026	0001968047

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	DRTS	Ordinary Shares						1,250,941	18 Mar 2026	Direct
holding	DRTS	Ordinary Shares						321,020	18 Mar 2026	Held through spouse
holding	DRTS	Restricted Share Units						4,680	18 Mar 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	DRTS	Options							18 Mar 2026	Ordinary Shares	54,318	$1.10	Direct	F2
holding	DRTS	Options							18 Mar 2026	Ordinary Shares	54,318	$4.42	Direct	F2
holding	DRTS	Options							18 Mar 2026	Ordinary Shares	24,727	$11.50	Direct	F2
holding	DRTS	Options							18 Mar 2026	Ordinary Shares	8,945	$10.92	Direct	F2
holding	DRTS	Options							18 Mar 2026	Ordinary Shares	10,657	$7.19	Direct	F2
holding	DRTS	Options							18 Mar 2026	Ordinary Shares	46,905	$3.28	Direct	F2
holding	DRTS	Options							18 Mar 2026	Ordinary Shares	43,257	$2.98	Direct	F2
holding	DRTS	Options							18 Mar 2026	Ordinary Shares	24,460	$4.05	Direct	F2
holding	DRTS	Options							18 Mar 2026	Ordinary Shares	15,527	$6.41	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These ordinary shares represent restricted share units, which will vest in their entirety upon the earlier of: one year commencing from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to the Reporting Person's continued service.
F2	These are options to acquire ordinary shares, which have fully vested as of the date hereof.
F3	These are options to acquire ordinary shares, which options will vest in their entirety upon the earlier of: one year commencing from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to the Reporting Person's continued service.